Close Menu

Testing the System

Britain's National Health Service aims to "test whether an entire health-care system is ready" for the personalized selection of cancer treatments via broad genetic testing, Nature News reports. "In its first phase, the program will be rolled out to as many as 12,000 NHS cancer patients over two years, beginning in early 2011," according to Nature.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.